Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...
This story is sponsored by Health Utah. Both starting and stopping this drug can be dangerous. Not only is the research clear about this but Dr. Roberts DC, at Heath Utah, is on the front lines ...
CINCINNATI — Weight loss drugs like Ozempic and Wegovy just became significantly more affordable, with savings of nearly $1,000 per month available at Costco. But doctors say there's an important ...
GLP-1s may shrink the scale, but they can also shrink your muscle, especially your heart. When you stop the meds, dangerous belly fat often comes back fast and harder than before. Dr. Sean O’Mara ...
Weight loss drug stigma shows society still holds negative attitudes towards body weight and obesity
Beverley O'Hara is affiliated with The Association for the Study of Obesity. Jordan Beaumont receives funding from NIHR. He is affiliated with the Association for the Study of Obesity. But while these ...
The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
Jonah Hill is committing to his next movie role in a major way. The Wolf of Wall Street star looked unrecognizable in an eccentric costume highlighting his significant weight loss as he stepped out on ...
The rise of GLP-1 receptor agonist drugs prescribed for weight loss and type 2 diabetes could be compromising the interpretation of some cancer scans and throwing doctors off course. This is the ...
Amy Schumer is feeling good in her skin, and she knows you know it. In true comic fashion, the Emmy-winning actress and comedian, 44, playfully addressed her weight-loss transformation after receiving ...
Skye Biosciences (NASDAQ:SKYE) has dropped ~60% in premarket trading Monday after saying that its weight loss asset nimacimab missed its key endpoint in a phase 2a trial. Nimacimab, a CB1 inhibitor ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other? How do side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback